Diciembre 2005

Documentos

• Monografía Cocaina. Addicciones, vol. 13, suplemento 2 (2001)
• Estrategia Nacional sobre Drogas. Plan de Acción 2005-2008. Ministerio de Sanidad y Consumo
• Cocaína y Crack. En: Informe anual 2004. El problema de la drogodependencia en la Unión Europea y en Noruega . Luxemburgo: Oficina de Publicaciones Oficiales de las Comunidades Europeas, OEDT, 2004
• World Drug Report 2005. Office on Drugs and Crime. United Nations
• Drogas y Democracia en Latinoamérica: El Impacto de las Políticas Estadounidenses. Fundación Seguridad y Democracia
• Cocaína. Wikipedia
• Cocaine. Office of National Drug Control Policy
• Cocaine. Drug Enforcement Administration (DEA)
• Cocaine. eMedicine.com
• History of Cocaine, Medical Use. Recreational Drugs Information
• History of Cocaine. Narconon
• Cocaine. Abuse and Addiction. National Institute on Drug Abuse
• Cocaina: Consumo y efectos. Dirección de Drogodependencias del Gobierno Vasco
• ¿Estaba intoxicado por cocaína este individuo? (I): estimaciones basadas en la farmacocinética de la droga. Cuadernos de Medicina Forense nº 33 (julio 2003)
• Intoxicación por cocaína. Federación Panamericana de Asociaciones de Facultades (Escuelas) de Medicina
• Consumidores de cocaína: del uso recreativo al consumo adictivo. Una propuesta de intervención preventiva y asistencial. Doyma
• Terminology and information on drugs. Office on Drugs and Crime. United Nations. Office on Drugs and Crime. United Nations
• Lessons Learned in Drug Abuse Prevention: A Global View. Office on Drugs and Crime. United Nations
• ¡Un buen comienzo!. Buenas prácticas para utilizar una evaluación de la situación local a fin de iniciar un proyecto de prevención del uso indebido de sustancias nocivas por los jóvenes. Office on Drugs and Crime. United Nations
• Global initiative on primary prevention of substance abuse. Assessing and planning for substance abuse prevention among youth. Self evaluation instrument. Office on Drugs and Crime. United Nations
• Neurociencia del consumo y dependencia de sustancias psicoactivas. Organización Mundial de la Salud
• Systematic review of pharmacological treatment of cocaine dependence. Mental Health and Substance Dependence Department. World Health Organization
• Por qué invertir en el tratamiento del abuso de drogas: Documento de debate para la formulación de políticas. Oficina contra la Droga y el Delito. Naciones Unidas
• Tratamiento contemporáneo del abuso de drogas: Análisis de las pruebas científicas. Oficina contra la Droga y el Delito. Naciones Unidas
• Abuso de drogas: tratamiento y rehabilitación. Guía práctica de planificación y aplicación. Oficina contra la Droga y el Delito. Naciones Unidas
• Tratamiento del abuso de sustancias y atención para la mujer: Estudios monográficos y experiencia adquirida. Oficina contra la Droga y el Delito. Naciones Unidas
• Bola de nieve. Guía para la formación de usuarios/as de drogas como agentes de salud. Grupo Interdisciplinar sobre Drogas
• La oferta de drogas y los programas de intervención. Grupo Interdisciplinar sobre Drogas
• Indicadores de calidad en comunidad terapéutica. Federación Europea de Asociaciones de profesionales en Drogodependencias

Medline

• Cocaine cardiovascular toxicity.
  Karch SB.
  South Med J. 2005 Aug;98(8):794-9.
• Acute neonatal effects of cocaine exposure during pregnancy.
  Bauer CR, Langer JC, Shankaran S, Bada HS, Lester B, Wright LL, Krause-Steinrauf H, Smeriglio VL, Finnegan LP, Maza PL, Verter J.
  Arch Pediatr Adolesc Med. 2005 Sep;159(9):824-34.
• The effects and management of crack cocaine dependence.
  McClelland GT.
  Nurs Times. 2005 Jul 19-25;101(29):26-7.
• Use of dopamine agonist pergolide in outpatient treatment of cocaine dependence.
  Focchi GR, Leite MC, Andrade AG, Scivoletto S.
  Subst Use Misuse. 2005;40(8):1169-77.
• Vaccine pharmacotherapy for the treatment of cocaine dependence.
  Martell BA, Mitchell E, Poling J, Gonsai K, Kosten TR.
  Biol Psychiatry. 2005 Jul 15;58(2):158-64.
• Pituitary infarction resulting from intranasal cocaine abuse.
  Insel JR, Dhanjal N.
  Endocr Pract. 2004 Nov-Dec;10(6):478-82.
• The effect of alcohol on the neuropsychological functioning of recently abstinent cocaine-dependent subjects.
  Abi-Saab D, Beauvais J, Mehm J, Brody M, Gottschalk C, Kosten TR.
  Am J Addict. 2005 Mar-Apr;14(2):166-78.
• Cognitive impairment in acute cocaine withdrawal.
  Kelley BJ, Yeager KR, Pepper TH, Beversdorf DQ.
  Cogn Behav Neurol. 2005 Jun;18(2):108-12.
• Effects of prenatal cocaine/polydrug use on maternal-infant feeding interactions during the first year of life.
  Minnes S, Singer LT, Arendt R, Satayathum S.
  J Dev Behav Pediatr. 2005 Jun;26(3):194-200.
• Cocaine-induced acute hepatitis and thrombotic microangiopathy.
  Abd El-Rahman AM, Ammar H.
  JAMA. 2005 Jun 8;293(22):2715; author reply 2715-6.
• Cocaine and subarachnoid hemorrhage.
  Tang BH.
  J Neurosurg. 2005 May;102(5):961-2.
• The role of endocannabinoid transmission in cocaine addiction.
  Arnold JC.
  Pharmacol Biochem Behav. 2005 Jun;81(2):396-406.
• The effect of individual cocaine withdrawal symptoms on outcomes in cocaine users.
  Sofuoglu M, Dudish-Poulsen S, Poling J, Mooney M, Hatsukami DK.
  Addict Behav. 2005 Jul;30(6):1125-34. Epub 2004 Nov 2.
• Neurocognitive deficits in cocaine users: a quantitative review of the evidence.
  Jovanovski D, Erb S, Zakzanis KK.
  J Clin Exp Neuropsychol. 2005 Feb;27(2):189-204.
• Cocaine dependence and attention switching within and between verbal and visuospatial working memory.
  Kubler A, Murphy K, Garavan H.
  Eur J Neurosci. 2005 Apr;21(7):1984-92.
• Clinical implications of cocaine-induced cortical depression.
  Dackis CA, O'brien CP.
  Neuropsychopharmacology. 2005 May;30(5):1033; author reply 1034-5.
• Gender effects following repeated administration of cocaine and alcohol in humans.
  McCance-Katz EF, Hart CL, Boyarsky B, Kosten T, Jatlow P.
  Subst Use Misuse. 2005;40(4):511-28.
• Characteristics of cocaine users presenting to an emergency department chest pain observation unit.
  Booth BM, Weber JE, Walton MA, Cunningham RM, Massey L, Thrush CR, Maio RF.
  Acad Emerg Med. 2005 Apr;12(4):329-37.
• Desipramine treatment for cocaine dependence in buprenorphine- or methadone-treated patients: baseline urine results as predictor of response.
  Dsten T, Sofuoglu M, Poling J, Gonsai K, Oliveto A.
  Am J Addict. 2005 Jan-Feb;14(1):8-17.
• Reboxetine for the treatment of patients with Cocaine Dependence Disorder.
  Szerman N, Peris L, Mesias B, Colis P, Rosa J, Prieto A; Grupo de Estudio del Uso de Reboxetina en Dependencia a Cocaina.
  Hum Psychopharmacol. 2005 Apr;20(3):189-92.
• Predictors of alcohol and crack cocaine use outcomes over a 3-year follow-up in treatment seekers.
  McKay JR, Foltz C, Stephens RC, Leahy PJ, Crowley EM, Kissin W.
  J Subst Abuse Treat. 2005;28 Suppl 1:S73-82.
• Prize reinforcement contingency management for cocaine dependence: integration with group therapy in a methadone clinic.
  Petry NM, Martin B, Simcic F Jr.
  J Consult Clin Psychol. 2005 Apr;73(2):354-9.
• Palatal and nasal necrosis resulting from cocaine misuse.
  Goodger NM, Wang J, Pogrel MA.
  Br Dent J. 2005 Mar 26;198(6):333-4.
• Nefazodone in out-patient treatment of inhaled cocaine dependence: a randomized double-blind placebo-controlled trial.
  Passos SR, Camacho LA, Lopes CS, dos Santos MA.
  Addiction. 2005 Apr;100(4):489-94.
• Cocaine use and the occurrence of panic attacks in the community: a case-crossover approach.
  O'Brien MS, Wu LT, Anthony JC.
  Subst Use Misuse. 2005;40(3):285-97.
• Cocaine-induced myocardial infarction associated with severe reversible systolic dysfunction and pulmonary edema.
  Arzola-Castaner D, Johnson C.
  P R Health Sci J. 2004 Dec;23(4):319-22.
• Cocaine-related torsade de pointes in a methadone maintenance patient.
  Krantz MJ, Rowan SB, Mehler PS.
  J Addict Dis. 2005;24(1):53-60.
• Cocaine Rapid Efficacy Screening Trial (CREST): a paradigm for the controlled evaluation of candidate medications for cocaine dependence.
  Leiderman DB, Shoptaw S, Montgomery A, Bloch DA, Elkashef A, LoCastro J, Vocci F.
  Addiction. 2005 Mar;100 Suppl 1:1-11.
• Safety and efficacy of L-tryptophan and behavioral incentives for treatment of cocaine dependence: a randomized clinical trial.
  Jones HE, Johnson RE, Bigelow GE, Silverman K, Mudric T, Strain EC.
  Am J Addict. 2004 Oct-Dec;13(5):421-37.
• Injecting and non-injecting cocaine use in Sydney, Australia: physical and psychological morbidity.
  Kaye S, Darke S.
  Drug Alcohol Rev. 2004 Dec;23(4):391-8.
• Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments.
  Kreek MJ, Bart G, Lilly C, LaForge KS, Nielsen DA.
  Pharmacol Rev. 2005 Mar;57(1):1-26.
• Retrospective analyses of pooled data from CREST I and CREST II trials for treatment of cocaine dependence.
  Elkashef A, Holmes TH, Bloch DA, Shoptaw S, Kampman K, Reid MS, Somoza E, Ciraulo D, Rotrosen J, Leiderman D, Montgomery A, Vocci F.
  Addiction. 2005 Mar;100 Suppl 1:91-101.
• Randomized controlled pilot trial of cabergoline, hydergine and levodopa/carbidopa: Los Angeles Cocaine Rapid Efficacy Screening Trial (CREST).
  Shoptaw S, Watson DW, Reiber C, Rawson RA, Montgomery MA, Majewska MD, Ling W.
  Addiction. 2005 Mar;100 Suppl 1:78-90.
• A placebo-controlled screening trial of tiagabine, sertraline and donepezil as cocaine dependence treatments.
  Winhusen TM, Somoza EC, Harrer JM, Mezinskis JP, Montgomery MA, Goldsmith RJ, Coleman FS, Bloch DA, Leiderman DB, Singal BM, Berger P, Elkashef A.
  Addiction. 2005 Mar;100 Suppl 1:68-77.
• A medication screening trial evaluation of reserpine, gabapentin and lamotrigine pharmacotherapy of cocaine dependence.
  Berger SP, Winhusen TM, Somoza EC, Harrer JM, Mezinskis JP, Leiderman DB, Montgomery MA, Goldsmith RJ, Bloch DA, Singal BM, Elkashef A.
  Addiction. 2005 Mar;100 Suppl 1:58-67.
• A placebo-controlled screening trial of olanzapine, valproate, and coenzyme Q10/L-carnitine for the treatment of cocaine dependence.
  Reid MS, Casadonte P, Baker S, Sanfilipo M, Braunstein D, Hitzemann R, Montgomery A, Majewska D, Robinson J, Rotrosen J.
  Addiction. 2005 Mar;100 Suppl 1:43-57.
• A placebo-controlled screening trial of celecoxib for the treatment of cocaine dependence.
  Reid MS, Angrist B, Baker S, Woo C, Schwartz M, Montgomery A, Majewska D, Robinson J, Rotrosen J.
  Addiction. 2005 Mar;100 Suppl 1:32-42.
• Nefazodone treatment of cocaine dependence with comorbid depressive symptoms.
  Ciraulo DA, Knapp C, Rotrosen J, Sarid-Segal O, Ciraulo AM, LoCastro J, Greenblatt DJ, Leiderman D.
  Addiction. 2005 Mar;100 Suppl 1:23-31.
• Efficacy screening trials of paroxetine, pentoxifylline, riluzole, pramipexole and venlafaxine in cocaine dependence.
  Ciraulo DA, Sarid-Segal O, Knapp CM, Ciraulo AM, LoCastro J, Bloch DA, Montgomery MA, Leiderman DB, Elkashef A.
  Addiction. 2005 Mar;100 Suppl 1:12-22.
• Abdominal complications from crack cocaine.
  Maddox PR, Gardner-Thorpe D.
  Ann R Coll Surg Engl. 2005 Jan;87(1):72-3.
• Cocaine-induced acute hepatitis and thrombotic microangiopathy.
  Balaguer F, Fernandez J, Lozano M, Miquel R, Mas A.
  JAMA. 2005 Feb 16;293(7):797-8.
• Cardiovascular complications associated with cocaine use.
  Velasquez EM, Anand RC, Newman WP 3rd, Richard SS, Glancy DL.
  J La State Med Soc. 2004 Nov-Dec;156(6):302-10; quiz 311.
• Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence.
  Schottenfeld RS, Chawarski MC, Pakes JR, Pantalon MV, Carroll KM, Kosten TR.
  Am J Psychiatry. 2005 Feb;162(2):340-9.
• The effect of 12-step self-help group attendance and participation on drug use outcomes among cocaine-dependent patients.
  Weiss RD, Griffin ML, Gallop RJ, Najavits LM, Frank A, Crits-Christoph P, Thase ME, Blaine J, Gastfriend DR, Daley D, Luborsky L.
  Drug Alcohol Depend. 2005 Feb 14;77(2):177-84.
• Differences in impulsivity and sexual risk behavior among inner-city crack/cocaine users and heroin users.
  Lejuez CW, Bornovalova MA, Daughters SB, Curtin JJ.
  Drug Alcohol Depend. 2005 Feb 14;77(2):169-75.
• Novel approaches to the treatment of cocaine addiction.
  Sofuoglu M, Kosten TR.
  CNS Drugs. 2005;19(1):13-25.
• Treatment of cocaine dependence and depression.
  Rounsaville BJ.
  Biol Psychiatry. 2004 Nov 15;56(10):803-9.
• Dopamine mechanisms and cocaine reward.
  Ikegami A, Duvauchelle CL.
  Int Rev Neurobiol. 2004;62:45-94.